A reduction study of seroconversion of HBsAg in chronic hepatitis B patients with HBeAg positive by combination treatment with interferon and lamivudine.
- Author:
Shu-li YU
1
;
Lan-ying QIN
;
Can WANG
;
Li-jun YU
;
Chao-ying GUO
;
Yao-zong WANG
Author Information
1. Department of Infectious Diseases, Hospital of Infectious of Jinan, Jinan, China. yushuli999@126.com
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Antiviral Agents;
administration & dosage;
therapeutic use;
Child;
DNA, Viral;
blood;
Drug Therapy, Combination;
Enzyme-Linked Immunosorbent Assay;
Female;
Follow-Up Studies;
Hepatitis B Surface Antigens;
blood;
Hepatitis B e Antigens;
blood;
Hepatitis B virus;
drug effects;
Hepatitis B, Chronic;
blood;
drug therapy;
virology;
Humans;
Interferon-alpha;
administration & dosage;
therapeutic use;
Lamivudine;
administration & dosage;
therapeutic use;
Male;
Middle Aged;
Retrospective Studies;
Treatment Outcome;
Young Adult
- From:
Chinese Journal of Hepatology
2009;17(6):472-473
- CountryChina
- Language:Chinese
